Area of research
Economics and Econometrics · Genetics
Research interest
Research focused on Hazard ratio and Polygenic risk score, with related work in Deprescribing, Exome sequencing, Cumulative incidence. Notable publications include 'Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis', 'Returning integrated genomic risk and clinical recommendations: The eMERGE study', and 'Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis'.
Deprescribing interventions in older adults: An overview of systematic reviews
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States
Returning integrated genomic risk and clinical recommendations: The eMERGE study
US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)
Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis